Charted
Wednesday, Nov. 18, 2026The business of health, by the numbers
Live trackersDeal tracker $7.07B raisedFDA clearances 293 510(k)s in OctoberForm D raises $839M in 30 daysNew trials 266 Phase 2/3 in 30 days
Trackers · New trials

266Phase 2/3 in 30 days

Companies registered 266 new Phase 2 or Phase 3 interventional trials on ClinicalTrials.gov in the past 30 days, 117 of them Phase 3.

Industry-sponsored Phase 2 and 3 trials first posted, by week, past 12 weeksLow 44 · High 67 · Latest 60

Phase 3 trials first posted in the past 30 days (100 newest)

PostedTrialSponsorCondition
Nov. 17Study of Hexaxim Compared With Pentaxim Administered With a Monovalent Hepatitis B Vaccine in Healthy Chinese Infants.SanofiHaemophilus Influenzae Type b Immunisation; Hepatitis B Immunisation
Nov. 17A Study to Evaluate the Safety and Efficacy of Mavacamten in Adults With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy (SOLSTICE-HCM)Bristol-Myers SquibbNon-obstructive Hypertrophic Cardiomyopathy
Nov. 17Intravenous Recombinant Human Prourokinase (rhPro-UK) for Acute Ischemic Stroke Within 4.5 to 24 Hours of OnsetTasly Biopharmaceuticals Co., Ltd.Acute Ischemic Stroke AIS
Nov. 17A Study to Evaluate the Efficacy and Safety of BRC-201 in Patients With Acute Uncomplicated InfluenzaBoryung Biopharma Co., Ltd.Influenza
Nov. 17A Phase Ⅲ Clinical Trial of an Investigative 24-valent Pneumococcal Polysaccharide Conjugate VaccineReinovax Biologics Co., LTDPneumococcal Infectious Disease
Nov. 16The Efficacy and Safety of DLBS1442 in Patients With Primary DysmenorrheaDexa Medica GroupPrimary Dysmenorrhea
Nov. 16A Study to Assess the Effect of Pacibekitug on Major Cardiovascular Events in Patients After a Myocardial InfarctionNovartis PharmaceuticalsMyocardial Infarction
Nov. 16A Study to Evaluate the Long-term Safety and Efficacy of Fenebrutinib in Participants With Multiple Sclerosis (MS)Hoffmann-La RocheMultiple Sclerosis
Nov. 16The Efficacy and Safety of DLBS3233 in Adults With PrediabetesDexa Medica GroupPrediabetes
Nov. 13A Phase 3 Evaluation of Sutacimig in Glanzmann ThrombastheniaHemab ApSThrombasthenia
Nov. 13An Efficacy and Safety Study to Assess an Inhaled, Fixed-dose, Budesonide/Formoterol Fumarate in Participants Aged 4 to Less Than 12 Years of Age With Moderate Persistent AsthmaAstraZenecaAsthma
Nov. 13A Multicenter Study Evaluating the Efficacy and Safety of Nivolumab and Ipilimumab in Combination With NP-101 Versus Placebo in Refractory Advanced and Metastatic Gastroenteropancreatic Neuroendocrine Carcinomas (GEP-NECs)Novatek PharmaceuticalsGastroenteropancreatic Neuroendocrine Tumors
Nov. 13RC118 Combined With RC148 as First-Line Treatment for Claudin 18.2-Positive, HER2-Negative Advanced G/GEJ AdenocarcinomaRemeGen Co., Ltd.Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Nov. 13IIIb Trial for RC28-E Injection in Participants With DME and wAMDRemeGen Co., Ltd.Diabetic Macular Edema (DME); wAMD
Nov. 12A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and ExerciseNovo Nordisk A/SDiabetes Mellitus, Type 2
Nov. 12A Study to Evaluate the Safety and Efficacy (How Well the Study Treatment Works) of ABBV-2294 in Adult Participants With Systemic Sclerosis That Are Currently Receiving Local Standard of Care Treatment, and to Determine the Best Dose of ABBV-2294 to be Evaluated Further.AbbVieSystemic Sclerosis
Nov. 12Effect of S-Ibuprofen Gel on Pain in Acute Soft Tissue ContusionsAponia Laboratories, Inc.Acute Pain Due to Trauma
Nov. 12AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide in People With Type 2 Diabetes Treated With Metformin, SGLT2i, or BothNovo Nordisk A/SType 2 Diabetes
Nov. 12The Purpose of This Study is to Learn About the Safety and Effectiveness of Berobenatide in Women With Urine Leakage and With Obesity or OverweightPfizerUrinary Incontinence, Stress; Overweight and/or Obesity
Nov. 12A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin, and Placebo on LDL-C in LLT-naïve PatientsAstraZenecaHypercholesterolemia
Nov. 12[18F]FET PET for Differentiating Tumor Progression vs Treatment-Related Changes in Brain MetastasesTelix Pharmaceuticals (Innovations) Pty LimitedBrain Metastasis; Radiation Necrosis
Nov. 12A Study in Participants With Relapsed or Refractory Multiple Myeloma for QLS4131Qilu Pharmaceutical Co., Ltd.Relapsed or Refractory Multiple Myeloma
Nov. 12A Study to Investigate Long-term Safety and Tolerability of Frexalimab in Participants With Multiple SclerosisSanofiMultiple Sclerosis
Nov. 12Clinical Trial to Evaluate the Safety and Efficacy of DW4421 in Patients With Erosive Reflux DiseaseDaewon Pharmaceutical Co., Ltd.Erosive Reflux Disease; GERD (Gastroesophageal Reflux Disease)
Nov. 12A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease Treated With Once Daily Basal Insulin Alone or in Combination With Metformin, SGLT2i, or BothNovo Nordisk A/SType 2 Diabetes; Chronic Kidney Disease
Nov. 12A Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at Lower Dose Levels in People With Type 2 Diabetes Treated With Metformin, Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i), or BothNovo Nordisk A/SDiabetes Mellitus, Type 2
Nov. 10The Efficacy and Safety of Venglustat Compared With Cerezyme in Pediatric Participants 2 to 11 Years of Age With Gaucher Disease Type 3 (GD3)SanofiGaucher's Disease Type III
Nov. 10A Study to Test Obrixtamig Treatment in People With Different Types of Advanced Cancer Who Took Part in a Previous Study With ObrixtamigBoehringer IngelheimAdvanced Cancer
Nov. 10Efficacy and Safety of Polisorb® MP in the Complex Therapy of Patients With Atopic DermatitisPolisorb Joint Stock CompanyAtopic Dermatitis
Nov. 10A Study of Ceftobiprole Compared With Standard Antibiotic Treatment in Children With Staphylococcus Aureus Bacteremia (SAB) Infection, Including Right-sided Heart InfectionISTx, LLCStaphylococcus Aureus Bacteremia; Endocarditis, Bacterial
Nov. 10Continuation Study With Oral MC-1 for Treatment of Patients With PNPO-DeficiencyMedicurePyridox(am)Ine 5'-Phosphate Oxidase Deficiency
Nov. 9A Study to Assess the Safety of Marstacimab and How Well it Works in People With Mild to Moderate Hemophilia A or B Without InhibitorsPfizerHemophilia A or B
Nov. 9A Clinical Trial to Evaluate the Efficacy and Safety of Bevemipretide Ophthalmic Topical Solution in Subjects Who Have Dry Age-Related Macular Degeneration (Dry AMD)Mighty Therapeutics, Inc.Dry AMD; Age-Related Macular Degeneration (AMD)
Nov. 9Clinical Trial Evaluating the Efficacy and Safety of Navepegritide and Lonapegsomatropin in AchondroplasiaAscendis Pharma A/SAchondroplasia
Nov. 9A Study of SYS6010 Combined With Enlonstobart in Patients With Previously Systemic Treatment-Naive R/M Nasopharyngeal CarcinomaCSPC Megalith Biopharmaceutical Co.,Ltd.Previously Systemic Treatment-Naive Recurrent or Metastatic Nasopharyngeal Carcinoma
Nov. 9A Study of QLS5132 in Platinum-Resistant Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerQilu Pharmaceutical Co., Ltd.Epithelial Ovarian Cancer; Fallopian Tube Cancer
Nov. 9A Study Comparing Mesutoclax + Azacitidine Versus Venetoclax + Azacitidine in Untreated Acute Myeloid Leukemia (AML) PatientsBeijing InnoCare Pharma Tech Co., Ltd.Acute Myeloblastic Leukemia
Nov. 9A Randomized, Controlled, Double-Blind, Multicenter Phase III Clinical Trial to Evaluate the Efficacy and Safety of Enlonstobart, With or Without SYS6010 as Adjuvant Therapy, in Participants With Pathologically Residual Esophageal Squamous Cell Carcinoma Following Complete Surgical ResectionCSPC Megalith Biopharmaceutical Co.,Ltd.Esophageal Squamous Cell Carcinoma
Nov. 6An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)United TherapeuticsPulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease
Nov. 6Phase 2 and 3 Placebo Controlled & Long-term Extension Study of Rilzabrutinib in Adults With iCVID to Evaluate Efficacy, Safety, and TolerabilitySanofiImmunodeficiency Common Variable
Nov. 6Efficacy and Safety of Once-Weekly SHR-3167 Compared With Once-Daily Insulin Glargine in Adults With Insulin-Naive Type 2 DiabetesJiangsu HengRui Medicine Co., Ltd.Type 2 Diabetes
Nov. 6A Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These Participants May or May Not Also Have Type 2 DiabetesAstraZenecaObesity; Overweight
Nov. 5Two Trials to Evaluate TEV-53408 in Participants With Non-Segmental VitiligoTeva Branded Pharmaceutical Products R&D LLCVitiligo
Nov. 5A Clinical Trial of MK-1045 With Zilovertamab Vedotin in Participants With Diffuse Large B-cell Lymphoma (MK-1045-010)Merck Sharp & Dohme LLCLymphoma, Large B-Cell, Diffuse; Diffuse Large B-Cell Lymphoma
Nov. 5A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)PfizerObesity; Overweight
Nov. 5A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and ObesityNovo Nordisk A/SHypertension; Obesity
Nov. 5Pharmacokinetics, Immunogenicity and Safety of Subcutaneous Dupilumab and Berahyaluronidase Alfa (ALT-B4) CoformulationSanofiDermatitis Atopic
Nov. 5A Clinical Study Testing Enicepatide in Participants Living With Overweight or Obesity and Cardiovascular DiseaseHoffmann-La RocheOverweight; Obesity
Nov. 4A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2)PfizerObesity; Overweight and/or Obesity
Nov. 4A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)Boehringer IngelheimBronchiectasis
Nov. 4Efficacy of Two Brushing Regimens in the Reduction of Established Dental Plaque and GingivitisColgate PalmolivePlaque; Gingivitis
Nov. 4Roflumilast Cream 0.3% for Moderate to Severe Atopic DermatitisArcutis Biotherapeutics, Inc.Atopic Dermatitis; Atopic Dermatitis (AD)
Nov. 4Sintilimab Combined With LCCRT Followed by Capeox Chemotherapy in pMMR/MSS/MSI-L Locally Advanced Rectal CancerInnovent Biologics (Suzhou) Co. Ltd.Locally Advanced Rectal Cancer
Nov. 4A Study of Efficacy and Safety of FXS6837 in Anti-C5 Treated PNH Patients.Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.Paroxysmal Nocturnal Hemoglobinuria
Nov. 4A Clinical Trial to Evaluate Efficacy and Safety of Navepegritide Versus Placebo in Children and Adolescents With HypochondroplasiaAscendis Pharma A/SHypochondroplasia
Nov. 3HMPL-306 in Participants With Postoperative Residual or Recurrent Grade 2 Glioma Harboring IDH1 or IDH2 MutationsHutchmedGrade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation
Nov. 3Phase 3 Study of HS-10380 for Acute Schizophrenia in Chinese AdultsJiangsu Hansoh Pharmaceutical Co., Ltd.SCHIZOPHRENIA 1 (Disorder)
Nov. 3A Study Comparing SHR-3167 With Insulin Degludec in Adults With Type 2 Diabetes Currently Treated With Basal InsulinJiangsu HengRui Medicine Co., Ltd.Diabetes Mellitus, Type 2
Nov. 3rhTPO for Thrombocytopenia in Chronic Liver Disease Patients Undergoing Elective Invasive Procedures.MIBIO PTE. LTD.Thrombocytopenia Associated With Chronic Liver Disease
Nov. 3GFH375 Plus Cetuximab vs Investigator's Choice of Treatment in KRAS G12D-Mutant Refractory Metastatic Colorectal CancerGenfleet Therapeutics (Shanghai) Inc.Colorectal Cancer
Nov. 2A Study to Investigate the Efficacy and Safety of Zelicapavir Compared With Placebo in Adults With RSV Who Are at High Risk for Severe DiseaseEnanta Pharmaceuticals, IncRSV
Nov. 2A Clinical Trial of Gocatamig (MK-6070) With Durvalumab in Participants With Small Cell Lung Cancer (MK-6070-004)Merck Sharp & Dohme LLCSmall Cell Lung Cancer
Nov. 2Study of CM336+CM313 Combination Therapy in Patients With Relapsed or Refractory Multiple MyelomaKeymed Biosciences Co.LtdMultiple Myeloma (MM)
Nov. 2A Study to Evaluate Efficacy, Immunogenicity and Safety of a Recombinant Respiratory Syncytial Virus Vaccine in Older Adults Aged 60 Years and OlderGuangzhou Patronus Biotech Co., Ltd.Respiratory Syncytial Virus (RSV); Respiratory Syncytial Virus (RSV) Infection
Nov. 2A Study to Evaluate Surovatamig Combined With R-CHOP in Participants of 18 to < 80 Years of Age With Previously Untreated Large B-cell Lymphoma With IPI Score 2 to 5AstraZenecaLarge B-cell Lymphoma
Oct. 30A Study of JNJ-101556143 With Best Supportive Care in Participants With Metastatic Prostate CancerJanssen Research & Development, LLCProstatic Neoplasms
Oct. 30The AIRWARD Study: A Study to Test Whether Verducatib Helps People With Chronic Obstructive Pulmonary DiseaseBoehringer IngelheimChronic Obstructive Pulmonary Disease
Oct. 29To Evaluate Safety and Efficacy of Anitocabtagene Autoleucel Versus Autologous Stem Cell Transplant in Newly Diagnosed Multiple MyelomaKite, A Gilead CompanyNewly Diagnosed Multiple Myeloma
Oct. 29Specific Immunotherapy With Mannan-Conjugated Allergoids for HDM-Allergic Rhinitis/Rhinoconjunctivitis. MM09-SIT-063.Inmunotek S.L.Allergic Rhinitis; Allergic Rhinoconjunctivitis
Oct. 29A Randomized Study of ELVN-001 Versus Investigator-Selected TKI, in CP-CML Previously Treated With One or More TKIsEnliven TherapeuticsChronic Myeloid Leukemia (CML); Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
Oct. 29A Phase 3 Blinded Study of JADE101 in Participants With Immunoglobulin A NephropathyJade Biosciences, Inc.IgA Nephropathy (IgAN)
Oct. 29A Study to Evaluate the Efficacy and Safety of MG-K10 in Adults With Chronic Rhinosinusitis With Nasal PolypsShanghai Mabgeek Biotech.Co.LtdChronic Rhinosinusitis With Nasal Polyps
Oct. 29A Trial Comparing Ramantamig and Daratumumab (Ramantamig-D) Versus Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant EligibleJanssen Research & Development, LLCMultiple Myeloma
Oct. 29A Phase II/III Clinical Study of SIM0811 in the Treatment of Acute Ischemic StrokeJiangsu Simcere Pharmaceutical Co., Ltd.Acute Ischemic Stroke AIS
Oct. 29Specific Immunotherapy With Mannan-Conjugated Allergoids for HDM-Allergic Rhinitis/Rhinoconjunctivitis_MM09-SIT-069.Inmunotek S.L.Allergic Rhinitis; Allergic Rhinoconjunctivitis
Oct. 29HB0025-C-0301: A Study to Investigate HB0025 Combined With Chemotherapy as First-Line Treatment for Advanced or Recurrent MMR-proficient Endometrial CancerShanghai Huaota Biopharmaceutical Co., Ltd.First-line pMMR Endometrial Cancer
Oct. 28Study to Evaluate the Efficacy and Safety of Dexketoprofen / Butylscopolamine vs Dexketoprofen in Treatment of Primary DysmenorrheaLaboratorios Silanes S.A. de C.V.Primary Dysmenorrhea
Oct. 28Linvoseltamab Versus Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone (Dara-Vcd) in Adult Participants With Newly Diagnosed Systemic Light Chain AmyloidosisRegeneron PharmaceuticalsNewly Diagnosed Amyloidosis; Amyloidosis Stage I-IIIA
Oct. 28Zopapogene Imadenovec for the Treatment of Recurrent Respiratory Papillomatosis in ChildrenPrecigen, IncRecurrent Respiratory Papillomatosis (RRP); Juvenile-onset Recurrent Respiratory Papillomatosis
Oct. 28HRS-4642 Combined With Antitumor Agents for the Treatment of Perioperative Pancreatic CancerShanghai Hengrui Pharmaceutical Co., Ltd.Systemic Treatment-naïve Pancreatic Cancer
Oct. 28Study to Evaluate the Efficacy of a Single Intravitreal Injection of RTx-015 in Participants With Retinitis Pigmentosa (PERCEPT)Ray Therapeutics, Inc.Retinitis Pigmentosa (RP); Inherited Retinal Diseases
Oct. 28A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular RiskEli Lilly and CompanyObesity; Overweight
Oct. 28An Open-Label Study to Determine if BHV-1300 is Safe in Adults With Graves' DiseaseBiohaven Therapeutics Ltd.Graves' Disease
Oct. 27Safety and Efficacy of Weekly Testosterone Cypionate Auto-Injector in Men With HypogonadismAmneal Pharmaceuticals, LLCMale Hypogonadism
Oct. 27ASKC202 Plus Limertinib as the First-line Therapy for Patients With EGFRm+/MET+ Locally Advanced or Metastatic NSCLCJiangsu Aosaikang Pharmaceutical Co., Ltd.EGFR Activating Mutation; Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Oct. 27A Study to Evaluate Efficacy and Safety of HIP2602 in Erectile Dysfunction PatientsHanmi Pharmaceutical Company LimitedErectile Dysfunction
Oct. 27A Study to Assess the Efficacy and Safety of Pegcetacoplan for the Prevention of Recurrent C3G or Primary IC-MPGN in Kidney Transplant RecipientsSwedish Orphan BiovitrumC3 Glomerulopathy (C3G), Primary Immune-Complex Membranoproliferative Glomerulonephritis (IC-MPGN); Recurrent Glomerular Disease After Kidney Transplantation
Oct. 27A Study to Learn How Effective, Safe, and Tolerable Upadacitinib is for Young Participants With Non-segmental VitiligoAbbVieNon-Segmental Vitiligo
Oct. 27Orelabrutinib Plus ICP 248 vs Orelabrutinib for Relapsed/Refractory Marginal Zone LymphomaBeijing InnoCare Pharma Tech Co., Ltd.Relapsed/Refractory Marginal Zone Lymphoma (MZL)
Oct. 26QLC5508 vs. Investigator's Choice Chemotherapy in Advanced Extrapulmonary Neuroendocrine CarcinomaQilu Pharmaceutical Co., Ltd.Extrapulmonary Neuroendocrine Carcinoma
Oct. 26A Study of SHR-A1811 Combined With Adebrelimab for the First-line HER2-overexpressing Non-squamous Non-small Cell Lung CancerSuzhou Suncadia Biopharmaceuticals Co., Ltd.Non Small Cell Lung Cancer
Oct. 26SHR-A2009 Combined With Bevacizumab in the Treatment of Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer : a Randomized Controlled, Open, Multicenter Phase III StudySuzhou Suncadia Biopharmaceuticals Co., Ltd.Non-squamous Non-small Cell Lung Cancer
Oct. 26Efficacy And Safety of Olatorepatide in Adults With Overweight or Obesity Without DiabetesRegeneron PharmaceuticalsOverweight or Obesity Without Diabetes
Oct. 26A Phase III Clinical Study of HRS-6209 Plus Letrozole as First-line Therapy in Patients With Advanced or Metastatic Breast CancerJiangsu HengRui Medicine Co., Ltd.Breast Cancer
Oct. 22Study of a Combination SARS-CoV-2 Recombinant Spike and High-Dose Inactivated Influenza Vaccine With Matrix-M Adjuvant in Adult Participants 60 Years of Age and OlderSanofiImmunization; Healthy Volunteers
Oct. 22A Study of a Medicine Called Atirmociclib in Combination With Giredestrant in Adult Participants With ER-positive, HER2-negative Early-stage Breast CancerPfizerEarly Breast Cancer; Estrogen Receptor Positive (ER+), Human Epidermal Growth Factor Receptor 2 Negative (HER2-)
Oct. 22Combined Metabolic Activator Supplementation in Subjects Diagnosed With GoutScandiBio Therapeutics ABGout Disease
Oct. 22A Phase 3b Study of Participant Experience on Povetacicept Administered Via Autoinjector as Compared to Sibeprenlimab Administered Via Prefilled SyringeVertex Pharmaceuticals IncorporatedImmunoglobulin A Nephropathy
Oct. 22Master Protocol for the Study of Rilogrotug for the Treatment of Weight Loss and Anorexia in Patients With Cancer Cachexia and mCRC or mNSCLCAVEO Pharmaceuticals, Inc.Cachexia; Cancer; Cachexia
Oct. 22A Clinical Study to Evaluate the Effects of Enicepatide Versus Tirzepatide in Participants With Type 2 Diabetes and Inadequate Blood Sugar Control on Oral Glucose-Lowering MedicationsHoffmann-La RocheType 2 Diabetes Mellitus

How we count

Counts interventional studies whose lead sponsor is classed as industry and whose phase includes Phase 2 or Phase 3, by the date the record was first posted on ClinicalTrials.gov. First posting usually trails the sponsor's submission by days to weeks and does not mean enrollment has started. Phase 2/3 studies are counted once.

Newsletter

Charted Daily

The day's deals, FDA decisions and policy moves, by the numbers. Free. Sign up now to get the first edition.

No spam. Unsubscribe any time.